Renal Denervation in Chronic Kidney Disease - RDN-CKD Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 23, 2020

Primary Completion Date

December 23, 2023

Study Completion Date

December 30, 2023

Conditions
Uncontrolled HypertensionRenal DenervationChronic Kidney Disease stage3
Interventions
DEVICE

Renal denervation

The Paradise® Renal Denervation System (Paradise System) is CE-marked in countries accepting the CE mark. The system is a catheter-based device designed to use ultrasound energy to thermally ablate the afferent and efferent nerves surrounding the renal artery and serving the kidney.

Trial Locations (4)

40225

Heinrich Heine University Düsseldorf, Nephrologie, Germany, Düsseldorf

66421

Klinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Homburg

91054

Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen

Unknown

Clinical Research Center Nuremberg, Department of Nephrology, University Hospital Erlangen, Nuremberg

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER